Serrantor OCT Study

Recruiting now · Not applicable

Conditions studied: Critical Limb Ischemia

In brief

TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.

Key facts

Study ID

NCT06434194

Run by

Cagent Vascular LLC

People needed

60

Starts

2024-10-31

Expected to finish

2025-06-01

Last updated by the study team

2025-05-18

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Rutherford clinical category 4-6 of the target limb
• Age of subjects is >18 years old
• Patients has given informed consent to participate in this study

You may not qualify if…

• De novo or restenotic (without prior stent) stenosis (≥70%) or occlusion
• Target lesion is in the BTK arteries, including below the knee popliteal, tibioperoneal trunk, tibial, peroneal, and pedal arteries.
• Angiographic visual estimated reference vessel diameter is between 2.0 and 5.0 mm.
• Lesion length less than 220 mm

Where it is running

• Columbia University — New York, New York, United States (enrolling)
• Weill Cornell Medical — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.